The Pharmacology of Psychedelics
Log in to view the recording.
*Exclusive for members.
Thursday, August 26th at 5 pm Pacific, 8 pm Eastern >> Watch the Recording >>
Join Us For an EXCLUSIVE Panel Discussion for Members of The Psychedelic Medicine Association:
The Pharmacology of Psychedelics
Panel Moderator:
Lynn Marie Morski, MD, ESQ
President - Psychedelic Medicine Association
Panelists:
Benjamin Malcolm, PharmD, MPH, BCPP
Spirit Pharmacist
Dr. Ben Malcolm earned his bachelor’s degree (BS) in pharmacology at the University of California at Santa Barbara, prior to his Masters in Public Health (MPH) and Doctorate of Pharmacy (PharmD) at Touro University California. He then completed post-graduate residencies in Acute Care at Scripps Mercy Hospital and Psychiatric Pharmacy at the University of California at San Diego Health. After residency training he began his career as an Academician at Western University of Health Sciences (WUHS), College of Pharmacy and obtained Board Certification in Psychiatric Pharmacy (BCPP). He currently practices as a psychopharmacology consultant and a provides a resource and support membership relating to the use psychedelic and psychotropic medications at spiritpharmacist.com. Dr. Malcolm envisions a society in which access to psychedelic drugs in a variety of safe and supported settings is available for purposes of psychospiritual well-being, personal development, ceremonial sacraments, and treatment of mental illness. His vision guides his scholarship, education, and service-related professional activity.
Kelan Thomas, PharmD, MS, BCPP, BCPS
Associate Clinical Professor, University of California
Dr. Kelan Thomas, PharmD, MS, BCPP, BCPS is an Associate Professor of Clinical Sciences at Touro University California College of Pharmacy and Board Certified Psychiatric Pharmacist with outpatient behavioral health practice sites in the San Francisco Bay Area. He has conducted clinical research related to adverse drug reactions and pharmacogenomics with the goal of optimizing pharmacotherapy for mental health clients. In 2017, he completed the California Institute of Integral Studies Certificate in Psychedelic-Assisted Therapies and Research training program, began publishing psychedelic science articles and book chapters, while also collaborating on psychedelic clinical trials at University of California, San Francisco.
We’ve all heard the incredible promise of psychedelic therapies: how just a few sessions can have a curative effect on some conditions and significantly improve others.
But as with any other medicine, psychedelic medicines come with their own pharmacology – meaning that there’s a lot to learn regarding dosing, side effects, and drug-drug interactions.
A number of questions arise along these lines. Are psychedelics addictive? Can patients develop tolerance to psychedelics? Will psychedelic medicines interact with other medications?
To answer those questions, we are honored to have two panelists on this month’s webinar to cover:
- Medication interactions
- Tolerance profiles
- Addiction potential (or lack thereof)
- Microdosing considerations
…and much more!
As always, there will be ample time for audience Q & A, so you’ll get to interact with the panelists directly!
So please join us for this live panel discussion on Thursday, August 26th at 5 pm Pacific, 8 pm Eastern. This is exclusively for members of the Psychedelic Medicine Association, so if you have not yet registered, please do so here. And for members, please register for the panel here. A link to the recording will be available afterward if you cannot make it to the live event.
Hope to see you all on the 26th!
You can find the Psychedelic Medicine Association on Twitter, LinkedIn, and on Facebook.